Kiniksa Pharmaceuticals

Price & Volume

Stats

See more
52W Range
$19.62-$50.03
Market Cap
$3.5B
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$677.5M
Revenue Growth (YoY)
65%
Gross Profit (12 Mos)
$370.3M
Diluted EPS
$0.75

About

CEO
Mr. Sanj K. Patel
CFO
Mr. Mark A. Ragosa C.F.A.
Address
105 Piccadilly, London, United Kingdom, W1J 7NJ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
366